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Sickle cell anemia is still a significant public health issue in underdeveloped and developing 
countries. Sickle cell disease is one of the most common inherited diseases in Brazil. It affects 
mainly the mixed race population. Approximately 1 African-Brazilian child is affected with sickle 
cell disease for every 37,400 children born alive. Hearing loss has been considered one of the main 
clinical manifestations, especially in children. However, to date, there are just a hand full of studies 
in Brazil and the Brazilian state of Bahia has the largest African-descended population, attempting 
to establish the frequency of this event.
Objectives: To analyze the major studies associated with the subject, published in the last twenty 
years in the main indexed databases.
Methods: To use MEDLINE to identify the main papers published in English in medical literature, 
between January of 1989 and January of 2009; associating sickle cell anemia and hearing loss, with 
its clinical outcomes.
Conclusion: Given that it is always possible to attempt to prevent disabilities, understanding hearing 
loss in children with sickle cell anemia enables to maximize quality of life and provides for a broader 
school attendance.
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INTRODUCTION
Sickle cell (SC) anemia is a hereditary hemoglobin 
disorder associated with a very specific molecular lesion, 
which is the exchange of glutamic acid for valine in the 
6th residue of the hemoglobin beta chain, originating 
the S hemoglobin1.
Sickle cell anemia is still a public health issue in 
underdeveloped and developing countries. The sickle 
cell disease includes a group of genetic alterations cha-
racterized by the predominance of the S hemoglobin, 
which causes red blood cells to have the shape of a 
sickle. The main clinical manifestations of sickle cell 
anemia are a chronic anemia caused by the destruction 
of red blood cells (hemolytic type) and thrombotic 
events. Despite a variable disease severity, individuals 
affected require regular health care from childhood all 
the way to adult age2.
The S hemoglobin gene is highly frequent throu-
ghout the Americas, and in Brazil it is more frequent 
in the southeast and the northeast3. The S hemoglobin 
(HbS) reaches the frequency of 7.6% in the population 
from the Brazilian northeast, made up of 82% of blacks 
and browns3.
Hearing deficit is described as one of the symp-
toms which happen because of the cochlear high sensi-
tivity to vessel occlusion, causing ischemia and cochlear 
anoxia, because of the sickle cells which preclude blood 
flow to the cochlear epithelium4. The fact that the coch-
lea is mainly fed by one single artery, the labyrinthine 
artery, which can be a terminal artery, makes the inner 
ear very much prone to circulatory changes5.
The concern with the early diagnosis of hearing 
impairment has been a constant issue, since the loss 
caused by such impairment, often times is irreversible, 
affecting not only oral language, but also the child’s 
global development and school performance6.
Although sickle cell anemia has been broadly 
studied in Brazil in terms of population frequency and 
clinical manifestation, its public health issues associated 
with child-youth hearing loss has not received proper 
attention in our country.
In the present paper we reviewed the literature 
on sickle cell anemia and its clinical-audiologic reper-
cussions in children and adolescents, analyzing how 
the specialized literature discusses the topic in different 
methodological approaches.
OBJECTIVE
To use the literature from the past two decades to 
analyze which are the main findings on the dual: sickle 
cell anemia and hearing loss, and the later repercussions 
in individuals with sickle cell anemia.
MATERIALS AND METHODS
Identification and selection of papers
Using the MEDLINE database, we studied papers 
in the English language, published in the medical lite-
rature between January of 1989 and January of 2009, 
which reported associations between sickle cell anemia 
and hearing deficit, and its clinical repercussions. We 
reviewed Medline, Scielo, and Caribbean and Latin-Ame-
rican Literature on Health Sciences, with the following 
keywords: sickle cell disease; hearing loss; auditory dys-
function; stroke; prevalence; audiological evaluations; 
auditory electrophysiological assessments, used alone or 
in combination in our study. Based on the analysis of a 
list bearing one hundred and fifty-seven (157) references 
of relevant publications and review papers, we selected 
fifty-eight (58) papers which were the most relevant 
concerning the topic at hand.
LITERATURE REVIEW
Sickle Cell Anemia
Sickle cell anemia has an unknown origin, but it 
very likely started in Africa, millions of years ago. It pro-
tects people against malaria, a common and severe ail-
ment of warm weather countries. The first case described 
in contemporary medicine literature happened in 1910, 
by J. Henrick, and since then, numerous associations 
between the disease conditions and its complications 
have been described7.
The disease started in Africa, and it was brought 
to the Americas by the forced immigration of slaves. 
In Brazil, it is heterogeneously distributed, being more 
frequent where there are higher numbers of African des-
cendants (northeast). Besides Africa and the Americas, 
it is today found all over Europe and in large regions 
of Asia8.
In the USA, sickle cell anemia is considered a 
significant public health problem; one in every 400 
African-Americans is treated for sickle cell anemia in 
the public health care system9.
Sickle cell anemia, as clinical expression of the 
homozygosis of the S hemoglobin gene, is an important 
genetic abnormality in Brazil, especially in the regions 
which received large numbers of African slaves. In our 
country it is estimated that 3 for every 500 Brazilian-
Africans have sickle cell anemia trace and one for every 
500 blacks in Brazil is born with some form of the di-
sease. Although there is a higher prevalence in African-
descendants, the Caucasian population, especially those 
from the Mediterranean (Greece, Italy, etc.), Middle East, 
India, have many cases of sickle cell disease10.
In our country, the disease was considered 
predominant among blacks and browns; nonetheless, 
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new studies have shown that although the disease pre-
dominates among African-descendants, the growing 
mixture of races is opening the borders of this disease, 
unbundling it from ethnic links11.
In the state of Bahia, it was estimated that 5.5% of 
the general population bears a sickle cell trace, reaching 
6.3% of the African-descended population12. One study 
carried out with African-descended children in the city 
of Salvador, pointed to an even higher frequency: 7.4%13.
The decrease in the levels of O
2 
causes mor-
phological polymerization of the red blood cell, and 
it takes on an anomalous form, looking like a sickle. 
The elongated deformed red cells, not always can cross 
through small vessels, blocking them and preventing 
blood flow in the vicinity areas. The disease’s course is 
variable; there are patients who have severe problems 
with greater frequency and others who have only spo-
radic health problems.
In general, besides chronic anemia, the diffe-
rent forms of sickle cell diseases are characterized by 
numerous complications which may affect almost all 
organs and systems, with relevant morbidity, reduction 
in work capacity and in life expectancy. Besides chronic 
anemia manifestations, the clinical picture is dominated 
by osteocartilaginous pain episodes, abdominal pain, 
pulmonary infarctions and infections, growth and sexual 
maturation delays, stroke and chronic involvement of 
multiple organs, systems or body aparatuses14.
Usually, it is during the second half of the first 
year of the life of a child that the first symptoms of the 
disease manifest, except for the cases in which the blood 
test – to detect the disease, was carried out at birth or 
when the baby is in the nursery. It is common for the 
disease to manifest itself by the time the child reaches 
school age, and it is rare when this does not happen.
As per institutional policy, sickle cell anemia 
started to be “appreciated” in 1996 through the Sickle 
Cell Anemia Program of the Ministry of Health (PAF-
MS) which intends, within its general goals, to “promote 
educational actions, aiming at educating the population 
about the disease; to train health care professionals for 
prevention, diagnosis and treatment of the disease, and 
also to promote the active search for affected people”15.
Sickle Cell Anemia and Hearing Deficit
Sickle cell anemia is a world-wide disease, espe-
cially present in countries with blacks and mixed popu-
lations, where the SS sickle cell form is very common. 
A reduction in O
2
 levels causes the morphological poly-
merization of the red cell and it takes on an anomalous 
form resembling a scythe or sickle. The morphological 
change associated with the physiological change in the 
structure of the red cells drastically reduces the capacity 
to transport O
2 
through the body. Some authors report 
that the hearing deficit concurrent to sickle cell anemia 
is not associated with the classic symptoms, but rather 
to its pathogenesis.4
The relationship between sickle cell anemia and 
hearing loss has been clearly documented. There are 
numerous investigations correlating the peripheral sen-
sorial hearing deficit with a large variety of results. The 
prevalence of hearing deficit reported in the literature 
describes losses of mild to profound levels. Most of the 
cases have bilateral hearing loss; unilateral hearing loss 
is rarely described.16-19
A metanalysis study carried out on the hearing of 
individuals with sickle cell reported that the ischemia 
caused to the stria vascularis leads to hypoxia in the 
organ of Corti, especially in individuals with a large 
number of painful spells, which would indicate a signi-
ficant risk for the entire hearing system.20
Some studies have reported that the cochlear 
lesion is caused by the deformation of the red blood 
cell, which prevent proper blood supply to the high 
metabolic activity required to maintain the delicate ionic 
and electrical balance of the endolymph, and that the 
anoxia caused to the organ of Corti would cause ex-
tensive and progressive cochlear damage, which would 
justify the lack of otoacoustic emissions in individuals 
with sickle cell anemia.21
There are authors who have analyzed distortion 
product otoacoustic emissions (DPOAE) in two groups 
of twenty African-American children with and without 
sickle cell anemia, and concluded that the DPOAE were 
changed in children with sickle cell, especially in relation 
to an increase in DPOAE amplitude.22
A case-controlled study carried out in the USA, 
stratifying groups with different types of hemoglobin 
diseases (SS, SC, SB-thalassemia) for hearing assessment 
using Brainstem Auditory Evoked Potential (BAEP) to 
study the threshold, showed that the SS form had 80% 
of the individuals with a level of hearing impairment 
varying from mild to profound.23
Numerous studies (between 1988 and 2004) used 
different methodologies to determine the hearing impair-
ment in individuals with sickle cell, from conventional 
audiologic evaluation (tonal and vocal audiograms), cen-
tral auditory processing assessment, brainstem auditory 
evoked potential and otoacoustic emissions. The results 
obtained had different percentage values of hearing defi-
cit incidences, varying in the population groups studied 
between 12 and 66% among individuals with sickle cell 
anemia. One of the most employed techniques was the 
study of otoacoustic emission amplitudes, which showed 
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a considerable increase in the amplitude of otoacoustic 
emissions, bearing a considerable increase in response 
amplitude from children with sickle cell anemia.24-28
In African countries, such as Congo, with a 
predominance of black individuals, a study reported 
sudden hearing loss in individuals with sickle cell. The 
pathophysiology of the hearing loss was found to be as-
sociated with the fact that the vascular occlusion caused 
obliteration of the internal artery of the auditory terminal, 
thus causing ischemia and cochlear anoxia. The high 
sensitivity of the cochlea towards anoxia and its great 
fragility concerning external factors require an accurate 
and early audiological diagnosis, and also specialized 
care. The authors stress the need for regular audiological 
follow up in patients with sickle cell anemia.4
In Europe, there was a study carried out in Spain, 
with the Mediterranean population, describing two cases 
of sudden hearing loss in patients with sickle cell anemia, 
stressing the high cochlear sensitivity to arterial occlusion 
caused by the malformation of the red cells. The authors 
stress the need for prevention, diagnosis and treatment 
of the hearing loss caused by vascular occlusion led by 
sickle cell disease; and also the need for public health 
policies which support the rehabilitation of sickle-cell 
individuals with sensorineural hearing loss29.
A case-control study carried out in Nigeria, inves-
tigated the hearing function of 62 individuals at an age 
range between 7 and 30 years, with sickle cell anemia, 
found a sensorineural hearing loss above 30 dB in 40% 
of the individuals evaluated and in 5.5% in the control 
group. Hearing impairment installed progressively along 
the disease course, bilaterally and it reached speech 
frequencies. The authors stress the need for prevention, 
diagnosis and treatment of the hearing loss caused by 
the vascular occlusion which happens in sickle cell ane-
mia, and also the need for public health policies which 
support the rehabilitation of sickle cell individuals with 
sensorineural hearing loss30.
In Ghana, they carried out a study to establish the 
prevalence of sensorineural hearing loss in patients with 
sickle cell disease. Twenty-nine percent of the patients 
with sickle cell anemia had moderate sensorineural he-
aring loss, especially in the frequency range between 
4 and 8 KHz. In the study, the authors stress the need 
for studies with populations from different geographical 
areas for prevalence analysis.31
A case-control study carried out to assess hearing 
in patients with sickle cell anemia in Nigeria, showed 
that the hearing impairment reaches more the spee-
ch frequencies, and that the hearing deficit happens 
predominantly in the inner ear, having seen that tym-
panometric curves are normal, ruling out this type of 
problem in the middle ear (otitis), which could cause 
the hearing impairment32.
In Kenya, a retrospective study was carried out 
with 360 patients in the age range between 7 months and 
21 years, with bearers of the SS form of the sickle cell 
disease, who were submitted to neurological assessment. 
Numerous neurological sequelae were found: 67% of the 
patients had already had a stroke; 33%, seizures, visual 
disorders and hearing impairment, besides cerebellar 
degeneration, mental confusion and hallucinations. 
Multiple neurologic complications were described in 4 
patients. The authors ratify that in Kenyan patients, there 
is the need for longitudinal audiological and neurological 
follow up in individuals with sickle cell anemia.33
During the literature review carried out for this 
study, we found only one paper from southern Brazil, 
reporting hearing deficit associated with sickle cell 
disease in adults. The authors reported the occurrence 
of sensorineural hearing loss in 21.4% from the sickle 
cell disease group, compared to 3.6% from the control 
group without sickle cell anemia. The study indicated 
that southern patients with sickle cell anemia had a 
predisposition do develop sensorineural hearing loss 
when compared to the general population.34
Considering the major racial mix in Bahia, with a 
predominance of the black population, it is extremely 
relevant to know about and react early on concerning 
hearing impairment, especially concerning the pediatric 
population, in order to install prevention and diagnostic 
measures early on so as to avoid learning deficits and 
late schooling.
According to estimates from the World Health 
Organization, every year in Brazil we have about 3,500 
children born with sickle cell disease. Twenty percent of 
them will not reach five years of age, because of com-
plications directly associated with the disease itself. Only 
early diagnosis and proper treatment can change this 
scenario. According to data from APAE-Salvador, from 
August of 2000, when the “foot test” started, neonatal 
screening for hemoglobin diseases, allowed us to know 
the true incidence of such disease: 1,655 live newborns 
with sickle cell anemia and 1 child with sickle cell trace 
for every 17 births35.
Based on the analysis of studies carried out to 
date, we can see that knowing the magnitude of sickle 
cell disease, with many analysis variables and sequelae, 
hearing impairment in children and adolescents, often 
times is ultimately missed or underdiagnosed, which 
impairs early specialized intervention, especially in chil-
dren acquiring oral language or in those starting school.
Different diagnostic methods confirmed the great 
variety in the degree of hearing loss in patients with 
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sickle cell disease; nonetheless, the sensorineural hea-
ring loss type predominated in the studies considered, 
confirming the damage caused to the cochlea and the 
auditory nerve, caused by hypoxia stemming from the 
sickle shape of the red cells.
Thus, we emphasize the early detection of hearing 
loss through otoacoustic emission tests, which can be 
carried out together with the PKU test, contributing to 
a reduction in severity and facilitating early and syste-
matized intervention.
The Sickle Cell Anemia Program, developed by 
the Department of Health, with a very active participa-
tion of African-Brazilian activists as of the late 90’s, has 
tried to conceptualize that sickle cell anemia is much 
more than a disease, under to auspices of medicine 
alone36.
In the state of Bahia, in June of 2003, a program 
was installed for the prevention, diagnosis and integral 
medical care and education to people with sickle cell 
disease and other hemoglobin diseases, including the 
Brazilian Public Health system – SUS - in this program 
we can guarantee that it will cover the diagnostic tests 
for hemoglobin diseases for newborn children, as well 
as specific treatments for the sickle cell disease.
Therefore, as it is guaranteed by law, we believe it 
to be of fundamental importance to inform the families 
of these patients about their rights guaranteed by law 
which are often times unknown to them, and its clinical 
repercussions and sequelae so as to provide early and 
efficient treatment in order to minimize the repercussions 
it has on the linguistic and cognitive development of 
children with sickle cell anemia.
CONCLUSIONS
Having said this all, based on the literature review 
carried out, it is clear the need to prevent, diagnose and 
systematically follow up these children with sickle cell 
anemia, because hearing loss, when underdiagnosed or 
diagnosed very later on, may cause irreparable damage 
to the sickle-cell-affected individual’s linguistic, biop-
sychosocial and emotional developments.
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